Teekay CEO sells 132,884 shares after option exercise
Rhea-AI Filing Summary
TEEKAY CORP LTD (TK) reports that President and CEO Kenneth Hvid exercised stock options for 132,884 shares of common stock on September 11, 2026 at an exercise price of $5.81 per share and immediately sold 132,884 shares at a weighted average price of $14.2801 per share in open-market transactions. The exercised option for 132,884 underlying shares was fully used, leaving 0 derivative shares reported as held afterward, and no Rule 10b5-1 trading plan is indicated.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and Sale: 132,884 shares ($1.13M approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Hvid Kenneth
Role
President and CEO
Sold
132,884 shs ($1.90M)
Approx. gross sale proceeds
$1.90M
Approx. exercise cost
$772K
Approx. pre-tax spread
$1.13M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option ("Right to Buy") | 132,884 | $5.81 | $772K |
| Exercise | Common Stock | 132,884 | $5.81 | $772K |
| Sale | Common Stock F1 | 132,884 | $14.2801 | $1.90M |
Holdings After Transaction:
Stock Option ("Right to Buy") — 0 contracts (Direct);
Common Stock — 105,500 shares (Direct)
Footnotes (1)
- F1. The transaction was executed in multiple trades at prices ranging from $14.25 to $14.355. The price reported above reflects the weighted average sale price.
Key Figures
Shares sold: 132,884 shares
Weighted average sale price: $14.2801 per share
Option exercise price: $5.81 per share
+4 more
7 metrics
Shares sold
132,884 shares
Common stock sold by CEO Kenneth Hvid on September 11, 2026
Weighted average sale price
$14.2801 per share
Open-market sale of 132,884 Teekay common shares
Option exercise price
$5.81 per share
Stock option exercised for 132,884 underlying shares of common stock
Option shares exercised
132,884 shares
Stock Option ("Right to Buy") converted into common stock on September 11, 2026
Option expiration date
June 7, 2033
Original expiration date of the exercised stock option grant
Sale price range
$14.25–$14.355 per share
Price range of multiple trades comprising the 132,884-share sale
Derivative shares after exercise
0 shares
Stock Option ("Right to Buy") position following the reported exercise
Key Terms
Stock Option ("Right to Buy"), weighted average sale price, Rule 10b5-1 trading plan, derivative security
4 terms
Stock Option ("Right to Buy") financial
"security titled Stock Option ("Right to Buy") was exercised for 132,884"
weighted average sale price financial
"The price reported above reflects the weighted average sale price"
Rule 10b5-1 trading plan regulatory
"No Rule 10b5-1 trading plan is indicated for these transactions"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
derivative security financial
"Exercise or conversion of derivative security into common stock"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Teekay (TK) report for CEO Kenneth Hvid?
Teekay reported that CEO Kenneth Hvid exercised stock options for 132,884 shares of common stock at $5.81 per share and sold 132,884 shares in open-market transactions on September 11, 2026.
How many Teekay (TK) options did the CEO exercise and at what strike price?
The CEO exercised stock options covering 132,884 shares of Teekay common stock at an exercise price of $5.81 per share. These options were reported as fully exercised, with 0 derivative shares remaining from that grant afterward.
Were the September 11, 2026 Teekay (TK) insider trades made under a Rule 10b5-1 plan?
No. The filing’s Rule 10b5-1 checkbox is not marked as affirmative, and there is no footnote stating that the transactions were made pursuant to a Rule 10b5-1 trading plan.
What type of derivative security did the Teekay (TK) CEO exercise?
The CEO exercised a Stock Option ("Right to Buy") that was exercisable into 132,884 shares of Teekay common stock at $5.81 per share, with the option originally having an expiration date of June 7, 2033.
AI-generated analysis. How Rhea-AI works. Not financial advice.